Featured Research

from universities, journals, and other organizations

Novel Discovery In Dendritic Cell Signalling Pathways Pave The Way For New Therapeutic Targets

Date:
June 20, 2009
Source:
Agency for Science, Technology and Research (A*STAR), Singapore
Summary:
Scientists have discovered another signaling pathway for the activation and apoptosis, or programmed cell death, of dendritic cells.

Scientists from A*STAR's Singapore Immunology Network (SIgN) and the University of Milano-Bicocca, Italy, have discovered another signaling pathway for the activation and apoptosis, or programmed cell death, of dendritic cells[1] .

Related Articles


Led by Prof Paola Castagnoli, Scientific Director of SIgN and Associate Prof Francesca Granucci of the University of Milano-Bicocca, the team discovered that the well-studied immune receptor called CD14 in dendritic cells could be independently activated by bacterial fragments called liposaccharides or LPS. Once activated, the CD14 would initiate the NFAT[2] or nuclear factor of activated T-cells pathway, which would then activate the dendritic cells to trigger off the body's immune response. The scientists also discovered that the entire activation by CD14 was necessary to cause apoptosis.

Dendritic cells are the frontline sentinels in the body's defence mechanisms and they are potent inducers of an immune response against invading pathogens. Activated dendritic cells have a short life span, and scientists have observed that they undergo apoptosis in order to protect the body from the over-stimulation of the immune system, which could result in autoimmunity. This behaviour is supported by Prof Castagnoli and Associate Prof Granucci's findings.

"What is exciting is the link between CD14 activation and the NFAT pathway," explained Prof Castagnoli. "These findings have identified novel potential targets for the development of therapeutics against diseases that are involved with the CD14-NFAT pathway. For example, overexpression of CD14 has been associated with sepsis and chronic heart failure. New drugs that can modulate the CD14-NFAT pathway could provide treatments for such serious medical conditions."

Said Prof Philippe Kourilsky, Chairman of SIgN, "Prof Castagnoli has been contributing greatly to the area of dendritic cell regulation and this latest finding has contributed towards the growing body of knowledge on immunology. I am confident that the continued efforts by the team in SIgN and their partners in the University of Milano-Bicocca would spawn more innovative discoveries in the field of dendritic cell immunology."

The knowledge gleaned through the findings could also contribute to the creation of immunosuppressive agents that target NFAT activity. Currently, drugs[3] such as cyclosporine A and FK506, which are widely used in organ transplantation, work by shutting off a protein called calcineurin, which is needed for triggering the immune response and activating the NFAT pathway. However, these drugs also cause adverse side effects such as kidney damage. Agents that interfere with NFAT specifically in lymphocytes but not in dendritic cells could potentially have yield immunosuppressive activity but with reduced side effects leading to prolonged graft survival.

[1] Dendritic cells (DCs) are immune cells and form part of the mammalian immune system. Their main function is to process antigen material and present it on the surface to other cells of the immune system, thus functioning as antigen-presenting cells.

[2] NFATs are a family of transcription factors that have been shown to be the effectors in the immune response. They are involved in activities such as cell expansion and the release of immunological-related molecules from immune cells.

[3] Datamonitor report (2006): Market value for immunosuppressants used in transplantation is set to grow to US$4.3 billion by 2015.


Story Source:

The above story is based on materials provided by Agency for Science, Technology and Research (A*STAR), Singapore. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ivan Zanoni, Renato Ostuni, Giusy Capuano, Maddalena Collini, Michele Caccia, Antonella Ellena Ronchi, Marcella Rocchetti, Francesca Mingozzi, Maria Foti, Giuseppe Chirico, Barbara Costa, Antonio Zaza, Paola Ricciardi-Castagnoli & Francesca Granucci. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature, 15 June 2009

Cite This Page:

Agency for Science, Technology and Research (A*STAR), Singapore. "Novel Discovery In Dendritic Cell Signalling Pathways Pave The Way For New Therapeutic Targets." ScienceDaily. ScienceDaily, 20 June 2009. <www.sciencedaily.com/releases/2009/06/090615102034.htm>.
Agency for Science, Technology and Research (A*STAR), Singapore. (2009, June 20). Novel Discovery In Dendritic Cell Signalling Pathways Pave The Way For New Therapeutic Targets. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2009/06/090615102034.htm
Agency for Science, Technology and Research (A*STAR), Singapore. "Novel Discovery In Dendritic Cell Signalling Pathways Pave The Way For New Therapeutic Targets." ScienceDaily. www.sciencedaily.com/releases/2009/06/090615102034.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins